臨床ビッグデータ解析と薬理学的実験の統合による腱障害予防法の探索

1. Riley G. Tendinopathy--from basic science to treatment. Nat Clin Pract Rheumatol. (2008) 4:82–

9.

2. Millar NL, Silbernagel KG, Thorborg K, et al. Tendinopathy. Nat Rev Dis Primers. (2021) 7:1.

3. Carr AJ, Norris SH. The blood supply of the calcaneal tendon. J Bone Joint Surg Br. (1989)

71:100–1.

4. Heinemeier KM, Schjerling P, Heinemeier J, Magnusson SP, Kjaer M. Lack of tissue renewal in

human adult Achilles tendon is revealed by nuclear bomb (14)C. FASEB J. (2013) 27:2074–9.

5. Ohberg L, Lorentzon R, Alfredson H. Good clinical results but persisting side-to-side differences

in calf muscle strength after surgical treatment of chronic Achilles tendinosis: a 5-year follow-up.

Scand J Med Sci Sports. (2001) 11:207–12.

6. Kaux JF, Forthomme B, Goff CL, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J

Sports Sci Med, 10(2011), pp. 238-253.

7. Kostrominova TY, Brooks SV. Age-related changes in structure and extracellular matrix protein

expression levels in rat tendons. Age (Dordr). (2013) 35:2203–14.

8. Zhou B, Zhou Y, Tang K. An overview of structure, mechanical properties, and treatment for agerelated tendinopathy. J Nutr Health Aging. (2014) 18:441–8.

9. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders.

Rheumatology (Oxford). (2006) 45:508–21.

10. Minetto MA, Giannini A, McConnell R, Busso C, Torre G, Massazza G. Common

Musculoskeletal Disorders in the Elderly: The Star Triad. J Clin Med. (2020) 9:1216.

11. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature.

Clin Infect Dis. (2003) 36:1404–10.

12. Tsai WC, Yang YM. Fluoroquinolone-associated tendinopathy. Chang Gung Med J. (2011)

34:461–7.

13. Lewis T, Cook J. Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians

and a systematic review of the literature. J Athl Train. (2014) 49:422–7.

14. Tanne JH. FDA adds "black box" warning label to fluoroquinolone antibiotics. BMJ. (2008)

337:a816.

15. Zhao S, Nishimura T, Chen Y, et al. Systems pharmacology of adverse event mitigation by drug

combinations. Sci Transl Med. (2013) 5:206ra140.

16. Nagashima T, Shirakawa H, Nakagawa T, Kaneko S. Prevention of antipsychotic-induced

hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of

the molecular mechanism. Sci Rep. (2016) 6:26375.

17. Nagaoka K, Nagashima T, Asaoka N, et al. Striatal TRPV1 activation by acetaminophen

ameliorates dopamine D2 receptor antagonist-induced orofacial dyskinesia. JCI Insight. (2021)

6:e145632.

44

18. Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized

adverse drug event resource to accelerate drug safety research. Sci Data. (2016) 3:160026.

19. Yokoyama S, Tanaka Y, Nakagita K, Hosomi K, Takada M. Bleeding risk of warfarin and direct

oral anticoagulants in younger population: a historical cohort study using a Japanese claims

database. Int J Med Sci. (2018) 15:1686–93.

20. Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its

association with fluoroquinolone antibiotics and other potential risk factors in a managed care

population. Pharmacoepidemiol Drug Saf. (2006) 15:784–92.

21. Abate M, Silbernagel KG, Siljeholm C, et al. Pathogenesis of tendinopathies: inflammation or

degeneration?. Arthritis Res Ther. (2009) 11:235.

22. Bolon B. Mini-review: toxic tendinopathy. Toxicol Pathol. (2017) 45:834–7.

23. Wu F, Nerlich M, Docheva D. Tendon injuries: Basic science and new repair proposals. EFORT

Open Rev. (2017) 2:332–42.

24. Ge Z, Tang H, Chen W, et al. Downregulation of type I collagen expression in the Achilles tendon

by dexamethasone: a controlled laboratory study. J Orthop Surg Res. (2020) 15:70.

25. Wong MW, Tang YY, Lee SK, Fu BS, Chan BP, Chan CK. Effect of dexamethasone on cultured

human tenocytes and its reversibility by platelet-derived growth factor. J Bone Joint Surg Am.

(2003) 85:1914–20.

26. Zhang J, Keenan C, Wang JH. The effects of dexamethasone on human patellar tendon stem cells:

implications for dexamethasone treatment of tendon injury. J Orthop Res. (2013) 31:105–10.

27. Spoendlin J, Meier C, Jick SS, Meier CR. Oral and inhaled glucocorticoid use and risk of Achilles

or biceps tendon rupture: a population-based case-control study. Ann Med. (2015) 47:492–8.

28. Johannsen F, Olesen JL, Øhlenschläger TF, et al. Effect of Ultrasonography-guided corticosteroid

injection vs placebo added to exercise therapy for Achilles tendinopathy: a randomized clinical

trial. JAMA Netw Open. (2022) 5:e2219661.

29. Dietrich-Zagonel F, Aspenberg P, Eliasson P. Dexamethasone enhances Achilles tendon healing in

an animal injury model, and the effects are dependent on dose, administration time, and

mechanical loading stimulation. Am J Sports Med. (2022) 50:1306–16.

30. Riley G. Tendon and ligament biochemistry and pathology. Soft tissue rheumatology (2004) 2053:

3–39.

31. Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements.

Nat Methods. (2015) 12:357–60.

32. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. (2012)

9:357–9.

33. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without

a reference genome. BMC Bioinformatics. (2011) 12:323.

34. Jelinsky SA, Rodeo SA, Li J, Gulotta LV, Archambault JM, Seeherman HJ. Regulation of gene

expression in human tendinopathy. BMC Musculoskelet Disord. (2011) 12:86.

45

35. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent

protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. (2002)

20:87-90.

36. Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating

lentivirus vector. J Virol. (1998) 72:8150–7.

37. Kato M, Takada S, Kashida Y, Nomura M. Histological examination on Achilles tendon lesions

induced by quinolone antibacterial agents in juvenile rats. Toxicol Pathol. (1995) 23:385–92.

38. de Mos M, Koevoet W, van Schie HT, et al. In vitro model to study chondrogenic differentiation

in tendinopathy. Am J Sports Med. (2009) 37:1214–22.

39. Li Q, Peng S, Sheng Z, Wang Y. Ofloxacin induces oxidative damage to joint chondrocytes of

juvenile rabbits: excessive production of reactive oxygen species, lipid peroxidation and DNA

damage. Eur J Pharmacol. (2010) 626:146–53.

40. Thirupathi A, Freitas S, Sorato HR, et al. Modulatory effects of taurine on metabolic and oxidative

stress parameters in a mice model of muscle overuse. Nutrition. (2018) 54:158–64.

41. Yousefzadeh M, Henpita C, Vyas R, Soto-Palma C, Robbins P, Niedernhofer L. DNA damagehow and why we age?. Elife. (2021) 10:e62852.

42. Tryfidou DV, McClean C, Nikolaidis MG, Davison GW. DNA damage following acute aerobic

exercise: a systematic review and meta-analysis. Sports Med. (2020) 50:103–27.

43. Frippiat C, Chen QM, Remacle J, Toussaint O. Cell cycle regulation in H(2)O(2)-induced

premature senescence of human diploid fibroblasts and regulatory control exerted by the

papilloma virus E6 and E7 proteins. Exp Gerontol. (2000) 35:733–45.

44. Wang Y, Jin S, Luo D, et al. Functional regeneration and repair of tendons using biomimetic

scaffolds loaded with recombinant periostin. Nat Commun. (2021) 12:1293.

45. Wan M, Gray-Gaillard EF, Elisseeff JH. Cellular senescence in musculoskeletal homeostasis,

diseases, and regeneration. Bone Res. (2021) 9:41.

46. Yoshida K, Itoigawa Y, Wada T, et al. Association of superoxide-induced oxidative stress with

rotator cuff tears in human patients. J Orthop Res. (2020) 38:212–8.

47. Fu SC, Yeung MY, Rolf CG, Yung PS, Chan KM, Hung LK. Hydrogen peroxide induced

tendinopathic changes in a rat model of patellar tendon injury. J Orthop Res. (2018) 36:3268–74.

48. Pouzaud F, Bernard-Beaubois K, Thevenin M, Warnet JM, Hayem G, Rat P. In vitro discrimination

of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress. J Pharmacol Exp

Ther. (2004) 308:394–402.

49. Lowes DA, Wallace C, Murphy MP, Webster NR, Galley HF. The mitochondria targeted

antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial

membrane damage in human Achilles tendon cells. Free Radic Res. (2009) 43:323–8.

50. Talla V, Veerareddy P. Oxidative stress induced by fluoroquinolones on treatment for complicated

urinary tract infections in Indian patients. J Young Pharm. (2011) 3:304–9.

51. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free

46

Radic Biol Med. (2000) 29:222–30.

52. Radák Z, Takahashi R, Kumiyama A, et al. Effect of aging and late onset dietary restriction on

antioxidant enzymes and proteasome activities, and protein carbonylation of rat skeletal muscle

and tendon. Exp Gerontol. (2002) 37:1423–30.

53. Wunderli SL, Blache U, Beretta Piccoli A, et al. Tendon response to matrix unloading is

54.

55.

56.

57.

58.

59.

60.

61.

62.

determined by the patho-physiological niche. Matrix Biol. (2020) 89:11–26.

Wang F, Murrell GA, Wang MX. Oxidative stress-induced c-Jun N-terminal kinase (JNK)

activation in tendon cells upregulates MMP1 mRNA and protein expression. J Orthop Res. (2007)

25:378–89.

Best KT, Nichols AEC, Knapp E, et al. NF-κB activation persists into the remodeling phase of

tendon healing and promotes myofibroblast survival. Sci Signal. (2020) 13:eabb7209.

Chang C, Worley BL, Phaëton R, Hempel N. Extracellular glutathione peroxidase GPx3 and its

role in cancer. Cancers (Basel). (2020) 12:2197.

Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in

cancer. Biochem Pharmacol. (2021) 184:114365.

D’Ippolito G, Diabira S, Howard GA, et al. Low oxygen tension inhibits osteogenic differentiation

and enhances stemness of human MIAMI cells. Bone. (2006) 39:513–22

El Haddad M, Jean E, Turki A, et al. Glutathione peroxidase 3, a new retinoid target gene, is crucial

for human skeletal muscle precursor cell survival. J Cell Sci. (2012) 125:6147–56.

Han L, Yang X, Sun W, et al. The study of GPX3 methylation in patients with Kashin-Beck

Disease and its mechanism in chondrocyte apoptosis. Bone. (2018) 117:15–22.

Poulsen RC, Watts AC, Murphy RJ, Snelling SJ, Carr AJ, Hulley PA. Glucocorticoids induce

senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21

pathway: in vivo and in vitro evidence. Ann Rheum Dis. (2014) 73:1405–13.

Pastori D, Pignatelli P, Farcomeni A, et al. Aging-related decline of glutathione peroxidase 3 and

risk of cardiovascular events in patients with atrial fibrillation. J Am Heart Assoc. (2016)

5:e003682.

47

...